Holen Sie sich die Stockscreener-App
1.85
2.12%
-0.04
Handel nachbörslich:
1.79
-0.06
-3.24%
Schlusskurs vom Vortag:
$1.89
Offen:
$1.91
24-Stunden-Volumen:
543.71K
Relative Volume:
0.36
Marktkapitalisierung:
$172.28M
Einnahmen:
$34.48M
Nettoeinkommen (Verlust:
$-102.07M
KGV:
-1.2671
EPS:
-1.46
Netto-Cashflow:
$-104.90M
1W Leistung:
-4.64%
1M Leistung:
-11.90%
6M Leistung:
+68.18%
1J Leistung:
-2.63%
1-Tages-Spanne:
$1.78
$1.91
1-Wochen-Bereich:
$1.78
$1.96
52-Wochen-Spanne:
$0.66
$2.9995
Caribou Biosciences Inc Stock (CRBU) Company Profile
Firmenname
Caribou Biosciences Inc
Sektor
Branche
Telefon
510-982-6030
Adresse
2929 7TH STREET, SUITE 105, BERKELEY
Vergleichen Sie CRBU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
1.85 | 175.07M | 34.48M | -102.07M | -104.90M | -1.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-11-08 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-10-31 | Eingeleitet | Evercore ISI | Outperform |
| 2023-07-11 | Eingeleitet | Truist | Buy |
| 2022-02-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-12-01 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-08-17 | Eingeleitet | BofA Securities | Buy |
| 2021-08-17 | Eingeleitet | Citigroup | Neutral |
| 2021-08-17 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Caribou Biosciences Inc Aktie (CRBU) Neueste Nachrichten
What is Caribou Biosciences Inc.’s book value per shareJuly 2025 Action & Entry Point Confirmation Alerts - khodrobank.com
Backtesting results for Caribou Biosciences Inc. trading strategiesGap Down & Weekly Top Performers Watchlists - Newser
Chart based analysis of Caribou Biosciences Inc. trendsIndex Update & Fast Exit/Entry Strategy Plans - Newser
Caribou Biosciences Inc.’s volatility index tracking explained2025 Institutional Moves & Weekly High Return Stock Forecasts - Newser
Understanding Caribou Biosciences Inc.’s price movement2025 Price Action Summary & Safe Entry Trade Reports - Newser
Retail Trends: Will Caribou Biosciences Inc. benefit from green energy policiesEarnings Beat & Community Trade Idea Sharing Platform - khodrobank.com
Long term hold vs stop loss in Caribou Biosciences Inc.Treasury Yields & Fast Entry Momentum Trade Alerts - Newser
Price momentum metrics for Caribou Biosciences Inc. explainedEarnings Beat & Low Risk Entry Point Guides - Newser
News impact scoring models applied to Caribou Biosciences Inc.2025 Trade Ideas & Verified Swing Trading Watchlist - Newser
Caribou Biosciences Inc. stock trend outlook and recovery pathMarket Movement Recap & Reliable Breakout Forecasts - Newser
Can a trend reversal in Caribou Biosciences Inc. lead to recoveryRate Hike & Risk Managed Investment Entry Signals - Newser
Using Python tools to backtest Caribou Biosciences Inc. strategiesInsider Buying & Step-by-Step Swing Trade Plans - Newser
Caribou Biosciences Inc. stock daily chart insightsInsider Buying & Daily Entry Point Trade Alerts - Newser
Quantitative breakdown of Caribou Biosciences Inc. recent moveMarket Growth Summary & Free High Return Stock Watch Alerts - Newser
What recovery options are there for Caribou Biosciences Inc.Portfolio Return Summary & Long-Term Capital Growth Ideas - Newser
Gene Editing Market to Surpass USD 15.46 Billion by 2032, Fueled by Breakthroughs in CRISPR Technology and Precision Medicine – SNS Insider - GlobeNewswire Inc.
Aug Movers: What are the future prospects of Caribou Biosciences Inc.2025 Analyst Calls & Smart Investment Allocation Tips - khodrobank.com
Will Caribou Biosciences Inc. benefit from green energy policies2025 Buyback Activity & Growth Focused Stock Pick Reports - khodrobank.com
Caribou Biosciences Inc. stock prediction for this weekWeekly Loss Report & Verified Momentum Watchlists - Newser
Historical volatility pattern of Caribou Biosciences Inc. visualizedPortfolio Performance Summary & Step-by-Step Swing Trade Plans - Newser
Chartists Watching For Breakout in Caribou Biosciences Inc.July 2025 Sector Moves & High Return Trade Guides - beatles.ru
What the charts say about Caribou Biosciences Inc. today2025 Price Targets & AI Enhanced Trading Signals - Newser
Using economic indicators to assess Caribou Biosciences Inc. potentialJuly 2025 Outlook & Weekly Setup with High ROI Potential - Newser
Is a relief rally coming for Caribou Biosciences Inc. holdersJuly 2025 Action & Weekly Breakout Watchlists - Newser
Caribou Biosciences Inc.’s Price Action Aligns with Quant SignalsSwing Trade & Weekly Watchlist of Top Performers - beatles.ru
Why Caribou Biosciences Inc. is moving todayQuarterly Performance Summary & High Yield Equity Trading Tips - Newser
Is Caribou Biosciences Inc. forming a bottoming baseAnalyst Upgrade & Verified Swing Trading Watchlists - Newser
Finanzdaten der Caribou Biosciences Inc-Aktie (CRBU)
Umsatz
Nettogewinn
Free Cashflow
ENV
Caribou Biosciences Inc-Aktie (CRBU) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| MCCLUNG BARBARA G | Chief Legal Officer |
Feb 21 '25 |
Sale |
1.35 |
3,564 |
4,811 |
443,502 |
| Khan Ruhi Ahmad | Chief Business Officer |
Feb 21 '25 |
Sale |
1.35 |
3,564 |
4,811 |
66,936 |
| Kanner Steven | Chief Scientific Officer |
Feb 21 '25 |
Sale |
1.35 |
3,564 |
4,811 |
431,556 |
| Ryali Sriram | Chief Financial Officer |
Jan 29 '25 |
Buy |
1.42 |
17,360 |
24,651 |
17,360 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):